RXST
Companies
NASDAQ
RxSight Inc.
Health Care
$13.62
-$20.76 (-60.38%)
Price Chart
Overview
About RXST
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Market Cap
$2.2B
Volume
17.7M
Avg. Volume
16.5M
P/E Ratio
-33.91837
Dividend Yield
0.00%
Employees
320.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.57
Low Correlation
Volatility
High (0.48)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RXST shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.2B
Volume17.7M
P/E Ratio-33.92
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 26, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025